Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy

home-news-gatech

Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.

Via Georgia Tech

Read More…

David Tillmanns

VIEW ALL POSTS